Article
Review or Updates on the clinical pharmacokinetics of levetiracetam
2024-12-28
Abstract excerpt
Epilepsy is one of the five major neuropsychiatric disorders worldwide, primarily due to its high disability and mortality rates. Antiseizure medications (ASMs) are the first-line treatment for primary epilepsy. Levetiracetam (LEV), a broad-spectrum second ASM, has been approved for the treatment of focal seizures, as well as adjunctive therapy for myoclonic seizures and primary generalized tonic-clonic seizures....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 17a9a666-0046-56c6-9b87-91733d92335d
- DOI
- 10.22541/au.173536956.69101789/v1
